Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
about
PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cellsTransfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytesMolecular profiling of T-helper immune genes during dengue virus infectionThe Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus InfectionModeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug designIdentification of small molecules that disrupt signaling between ABL and its positive regulator RIN1Protocol dependence of sequencing-based gene expression measurementsMapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy.Targeting Molecular Recognition: Exploring the Dual Role of Functional Pseudoprolines in the Design of SH3 Ligands This work was supported by the Swiss National Science Foundation.MATE1 regulates cellular uptake and sensitivity to imatinib in CML patientsDifferentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell lineIdentification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome.Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritisScreening of a combinatorial homing peptide library for selective cellular delivery.Transcription factor binding predicts histone modifications in human cell linesThe HOXB4 homeoprotein promotes the ex vivo enrichment of functional human embryonic stem cell-derived NK cellsDengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells.Human genome replication proceeds through four chromatin states.Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetesCD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire.Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.Magnetic tweezers-based 3D microchannel electroporation for high-throughput gene transfection in living cells.Trans acting regulation of beta globin gene expression in erythroleukemia (K562) cells.Immunolocalization of phostensin in lymphatic cells and tissues.Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments.Functional test of PCDHB11, the most human-specific neuronal surface proteinSpontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulationsCompact and highly active next-generation libraries for CRISPR-mediated gene repression and activation.Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease.Use of a cocktail of spin traps for fingerprinting large range of free radicals in biological systems.Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector levelExpression of T cell receptor genes in human B cells.A review of molecular mechanisms of the anti-leukemic effects of phenolic compounds in honeyA Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.Development of a single-cell array for large-scale DNA fluorescence in situ hybridization.MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell diseaseIntact signal peptide of CD18, the beta-subunit of beta2-integrins, renders ruminants susceptible to Mannheimia haemolytica leukotoxin.
P2860
Q24297436-36A2A1DF-C183-4A31-B9EB-846F833A6ECFQ24674303-E40EE951-12D5-4509-A87C-E6B9F085296CQ27487753-87BD466D-36F2-4DFC-8844-E9E09A2ACB62Q27488224-B09C37AA-71E0-44FF-8996-64792D7863D3Q28478748-8D7CBE62-738F-4A5D-AB14-D12063761BE0Q28545055-CB6FEFBC-0050-4998-BC20-E03887065AF4Q28740405-C036AB3B-66B9-40D8-BE23-33EAD4C93687Q30009317-0DDF2CF9-C002-4C02-B67D-5C439139AC0FQ30168001-ADBD7DF2-E3B2-4960-96A5-DD24F320BBFAQ30313870-E05B294E-00B1-478B-8298-A005E6B95AECQ30479628-5E4F5AD7-F8A3-4ED0-8538-1196487B0A8CQ31105943-8345A4ED-B69E-4A99-A9E3-2EC46E2E1D0BQ33294656-CABC9A90-70B6-4663-9659-303D60DBBE44Q33556764-372EC230-C71C-433D-8763-BAE5F3464F08Q33938342-8CFA9D19-F98A-42DD-94D6-DCBE599CA666Q34217994-DC6A5050-2D5C-4614-8150-374DA1DE4E1DQ34326201-FA8C79AE-D26C-48CB-A81F-C10D93BE050DQ34364315-DF3C2E9F-9A59-4F48-9196-A9376F629C2AQ35018004-577A705D-CDB9-4B52-8465-6DAFEFFB5EE2Q35062538-7C669F28-7AA2-4F0B-AA88-A42502B45C2EQ35090593-CACB6224-5E1E-4C5D-A0E5-EF4B08357D85Q35157101-75921A5F-F305-4BA7-A087-EE54B6E1F39EQ35206562-A9DE55EA-AB4D-4F94-BF4D-B66B45451274Q35417791-DFF669F2-5DCF-4EDC-AB91-A1A9F0FD929DQ35556950-8D7E576A-FF86-4C65-9F3B-E31149963E6AQ35681770-644E441C-CF9B-43A3-9279-F600509A78AFQ35774320-C0ACDBBB-AD73-4FCA-B8BD-46D3BEBCF1C7Q35986705-5D25FF48-D869-47C3-B6DC-337A28D59538Q35996445-4BDA4837-7B87-47EB-B68D-501BD0F03B58Q36142402-39A6C240-0313-412D-B1A6-5B623E4EDC14Q36228076-23FD7722-0C20-4F7D-ADE8-87BF5C111006Q36295348-F09132EA-2832-418F-AAAD-4580325EAD1FQ36343066-E0573B6E-A623-4744-B429-F23B15797E7FQ36353274-57E078B6-FB5B-4B52-B023-8FC11DB12C37Q36432594-6D77F35D-E813-432A-A3CE-387638A71BC9Q36655896-5C588A18-2D86-455B-8C7A-42AE0E0AD07BQ36675265-7C2834FC-6C94-421F-98D6-FE579688E68FQ36736547-39C33B66-2392-4C77-8C31-7E1C3DD53A74Q37071189-228D6F51-C61E-4097-870E-A9E47D75E1ACQ37340872-5179CFA9-CC02-46B8-8980-BE57D948B031
P2860
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
description
1976 nî lūn-bûn
@nan
1976 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@ast
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@en
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@nl
type
label
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@ast
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@en
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@nl
prefLabel
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@ast
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@en
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@nl
P2093
P921
P3181
P356
P1476
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
@en
P2093
A Polliack
H Ben-Bassat
P304
P3181
P356
10.1002/IJC.2910180405
P407
P577
1976-10-15T00:00:00Z